Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox
Aidan Kane, Dee Carter
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 482-482
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

New Antifungal Agents with Azole Moieties
Melissa Martins Teixeira, Diogo Teixeira Carvalho, Emı́lia Sousa, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1427-1427
Open Access | Times Cited: 49
A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi
Thaila Fernanda dos Reis, Patrícia Alves de Castro, Rafael Wesley Bastos, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
A One Health approach to overcoming fungal disease and antifungal resistance
Michael Woods, Jason A. McAlister, Jennifer Geddes‐McAlister
WIREs Mechanisms of Disease (2023) Vol. 15, Iss. 4
Open Access | Times Cited: 33
Anti-Candida albicans Activity of Ononin and Other Secondary Metabolites from Platonia Insignis MART
Anderson França da Silva, Josivan Regis Farias, Danielle Cristine Gomes Franco, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1014-1014
Open Access | Times Cited: 32
Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections
Laís de Almeida Campos, Margani Taise Fin, Kelvin Sousa dos Santos, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 266-266
Open Access | Times Cited: 16
Synergistic antifungal effects and mechanisms of amantadine hydrochloride combined with azole antifungal drugs on drug-resistant Candida albicans
Xiuyun Li, Yuanyuan Zhi, Ximeng Duan, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Spectrum of activity and mechanisms of azole–bisphosphonate synergy in pathogenic Candida
Aidan Kane, Hue Dinh, Leona T. Campbell, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 6
Open Access | Times Cited: 3
Druggable Sterol Metabolizing Enzymes in Infectious Diseases: Cell Targets to Therapeutic Leads
W. David Nes, Minu Chaudhuri, David J. Leaver
Biomolecules (2024) Vol. 14, Iss. 3, pp. 249-249
Open Access | Times Cited: 2
A mechanism study on the synergistic effects of rifapentine and fluconazole against fluconazole-resistant Candida albicans in vitro
Yulian Wang, Yufei He, Tongkai Cai, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27346-e27346
Open Access | Times Cited: 2
Antifungal and antibiofilm effect of duloxetine hydrochloride against Cryptococcus neoformans and Cryptococcus gattii
Amanda Rodrigues Rehem, Letícia Rampazzo da Gama Viveiro, Evelyn Luzia de Souza Santos, et al.
Folia Microbiologica (2024) Vol. 69, Iss. 6, pp. 1247-1254
Closed Access | Times Cited: 2
A First-in-Class Pyrazole-isoxazole Enhanced Antifungal Activity of Voriconazole: Synergy Studies in an Azole-Resistant Candida albicans Strain, Computational Investigation and in Vivo Validation in a Galleria mellonella Fungal Infection Model
Sveva Pelliccia, Pasquale Russomanno, Simona Barone, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 14256-14276
Closed Access | Times Cited: 2
An Insight into Rational Drug Design: The Development of In-House Azole Compounds with Antimicrobial Activity
Daniel Ungureanu, Ovidiu Oniga, Cristina Moldovan, et al.
Antibiotics (2024) Vol. 13, Iss. 8, pp. 763-763
Open Access | Times Cited: 2
Azorean Black Tea (Camellia sinensis) Antidermatophytic and Fungicidal Properties
Chantal Fernandes, José Sousa-Baptista, Ana Filipa Lenha-Silva, et al.
Molecules (2023) Vol. 28, Iss. 23, pp. 7775-7775
Open Access | Times Cited: 6
Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
Jong H. Kim, Luisa W. Cheng, Kirkwood M. Land
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 787-787
Open Access | Times Cited: 10
Can amphotericin B and itraconazole be co-delivered orally? Tailoring oral fixed-dose combination coated granules for systemic mycoses
Raquel Fernández-García, D. Walsh, P. O’Connell, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 183, pp. 74-91
Open Access | Times Cited: 4
Synergistic Antifungal Interactions between Antibiotic Amphotericin B and Selected 1,3,4-thiadiazole Derivatives, Determined by Microbiological, Cytochemical, and Molecular Spectroscopic Studies
Agnieszka Dróżdż, Dominika Kubera, Adrianna Sławińska-Brych, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3430-3430
Open Access | Times Cited: 4
Synergistic activity of crocin and crocin loaded in niosomes alone and in combination with fluconazole against Candida albicans isolates: In vitro and in silico study
Sara Norozipor, Mehdi Bamorovat, Seyyed Amin Ayatollahi Mosavi, et al.
Journal de Mycologie Médicale (2024) Vol. 34, Iss. 2, pp. 101478-101478
Closed Access | Times Cited: 1
Bisphosphonates synergistically enhance the antifungal activity of azoles in dermatophytes and other pathogenic molds
Aidan Kane, Joanna G. Rothwell, Annabel Guttentag, et al.
mSphere (2024) Vol. 9, Iss. 6
Open Access | Times Cited: 1
Evaluation of biofilm formation and antimicrobial susceptibility (drug resistance) of Candida albicans isolates
Loretta Alvarez, Kubendiran Kumaran, B Nitha, et al.
Brazilian Journal of Microbiology (2024)
Closed Access | Times Cited: 1
Antimycotic activity of green tea phytocompounds against Candida glabrata
Priyanka Sirari, Jigisha Anand, Manjusha Tyagi, et al.
Environment Conservation Journal (2023) Vol. 24, Iss. 3, pp. 268-273
Open Access | Times Cited: 3
Increased Absorption and Inhibitory Activity against Candida spp. of Imidazole Derivatives in Synergistic Association with a Surface Active Agent
Florin Aonofriesei
Microorganisms (2023) Vol. 12, Iss. 1, pp. 51-51
Open Access | Times Cited: 3
Lecithin and Chitosan as Building Blocks in Anti-Candida Clotrimazole Nanoparticles
Lisa Myrseth Hemmingsen, Virginia Panzacchi, Lloyd Mbugua Kangu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 790-790
Open Access | Times Cited: 3
Mathematical Modeling of Fluconazole Resistance in the Ergosterol Pathway of Candida albicans
Paul K. Yu, Llewelyn Sotto Moron-Espiritu, Angelyn R. Lao
mSystems (2022) Vol. 7, Iss. 6
Open Access | Times Cited: 4
Environment by environment interactions (ExE) differ across genetic backgrounds (ExExG)
Kara Schmidlin, C. Brandon Ogbunugafor, Alexander Sastokas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Guaiazulene and aureusidin inhibit metabolic adaptability and virulence in Candida albicans by targeting the glyoxylate cycle under alternative carbon conditions
Rajesh P. Shastry, Sudeep D. Ghate, R. Shyama Prasad Rao, et al.
Green Chemistry Letters and Reviews (2024) Vol. 18, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top